Publication
A Structured Process to Identify Fit-for-Purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory Uses
Generating evidence from real-world data requires fit-for-purpose study design and data. ...
Publication
Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021
In June 2020, preliminary results for the Randomised Evaluation of COVID-19 Therapy ...
Publication
Alternative Analytic and Matching Approaches for the Prevalent New-User Design: A Simulation Study
Purpose To describe the creation of prevalent new user (PNU) cohorts and compare the ...
Publication
Frequency of opioid dispensing after vaginal delivery
Objective: To describe nationwide patterns in outpatient opioid dispensing after vaginal ...
Blog
Research spotlight: RWD transferability across borders
Manufacturers are increasingly using real-world data (RWD) to generate real-world ...
Article
Synthetic Data is Key to Privacy by Design Practices in New Canadian Smart City Partnership
This article by the International Association of Privacy Professionals covers the ...
Publication
Accelerating AI with Synthetic Data
This book published by O'Reilly focuses on advancements in generating high-quality ...
Podcast
Discussion with Dr. Khaled El Emam on synthetic data
In this podcast, called Unredacted, Replica Analytics’ SVP & GM, Khaled El Emam, is ...
Podcast
Real or Fake? The Buzz About Synthetic Data
In this podcast on InfoMatters, Replica Analytics’ SVP & GM, Khaled El Emam, is ...
Article
Precaution, Ethics & Risk: Perspectives on Regulating Non-identifiable Data
This article published by the International Association of Privacy Professionals delves ...
Podcast
Deciphering Deep Fakes & Synthetic Data
In a podcast on ThatTechPod, Khaled El Emam, SVP & GM of Replica Analytics discusses ...
Article
Replica Analytics Using Synthetic Data to Ease Medical Researchers’ Pain
This article in Ottawa Business Journal provides some background on Replica Analytics as ...
Article
10 Recommendations for Regulating Non-identifiable Data
This article published by the International Association of Privacy Professionals outlines ...
Q&A
CityAge Q&A with Khaled El Emam
This Q&A is published by CityAge. Replica Analytics’ SVP & GM, Khaled El Emam, ...
Article
Enabling Health Information Sharing with Synthetic Data
This article in Privacy Laws & Business discusses the surging demand for access to ...
Podcast
Privacy Tech Talk: May 18, 2022
This podcast on PrivacyTechTalk focuses on synthetic data generation, which is gaining ...
Article
Real-World Evidence Firm Aetion Grabs Privacy-Protected Synthetic Data Provider Replica Analytics
This article from Fierce Healthcare reports on Aetion's acquisition of Replica Analytics, ...
Article
Synthetic Data Paradigm for Using and Sharing Data
This article published by Cutter provides an overview of the use cases for synthetic ...
Blog
A Solution for Payers to Use Real World Evidence in Pharma Confidently
Tackling three common concerns
Article
What is synthetic data and how is it generated?
By Khaled El Emam | Published: February, 2023 The following article was published by ...
Presentation
Changing the Conversation on Privacy – Using Data For Good
Presentation
Generating and Evaluating Synthetic Clinical Trial Data in a Pharmaceutical Company
Presentation
A review of the new ISO Standard on Data De-identification: ISO/IEC 27559
Blog
RWE Meaning | Update: What the Omnibus FDA Amendments Mean for RWE
On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023, a ...